Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center Clinical Study for Assessment of the Consistency of the Results of Human Irregular Antibody Screening With Surgiscreen and Serascan Diana 3

NCT01589133 is registered in ClinicalTrials.gov with Johnson & Johnson Medical, China as lead sponsor.

NCT NCT01589133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01589133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center Clinical Study for Assessment of the Consistency of the Results of Human Irregular Antibody Screening With Surgiscreen and Serascan Diana 3
Lead sponsor
Johnson & Johnson Medical, China
Phase
Observational
Overall status
Completed
Start date
May 31, 2012
Completion date
October 31, 2012
Enrollment
3,109 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

irregular antibody screening